TLDR
- Oppenheimer started coverage of CoreWeave ($CRWV) with an Outperform rating and a $140 price target, implying ~92% upside from the current price of ~$72.83
- The firm cited AI infrastructure demand and CoreWeave’s positioning in the AI-optimized cloud market as key growth drivers
- Q4 revenue hit $1.57 billion, up 110% year-over-year, but EPS missed estimates at -$0.89 vs. -$0.61 expected
- Insider selling topped $373 million in the last quarter, and multiple class-action lawsuits have been filed following Q4 results
- Analyst consensus sits at “Moderate Buy” with an average price target of $122.35, though some analysts hold Sell ratings with targets as low as $56
Oppenheimer kicked off coverage of CoreWeave this week with a bullish call, setting a $140 price target and an Outperform rating. That target sits roughly 92% above where the stock was trading on Friday at around $72.83.
CoreWeave, Inc. Class A Common Stock, CRWV
The firm’s thesis centers on what it calls the “outsized TAM opportunity for AI-optimized IaaS.” In plain terms, Oppenheimer believes demand for AI computing infrastructure is growing fast, and CoreWeave is built specifically to serve it.
Analyst Param Singh argued that CoreWeave is well-positioned to compete not just against traditional hyperscalers, but also the newer wave of so-called “neo-cloud” providers targeting AI workloads.
One of the more contentious parts of the call is the CapEx question. CoreWeave is burning through capital at a rapid pace, and the company has a debt-to-equity ratio of 4.46. Oppenheimer addressed this directly, saying investor concerns about near-term spending are “short-sighted.”
The firm’s long-term model assumes free cash flow margins normalize above 25% by 2035, as growth cools and capital spending moderates.
Q4 Results Add Pressure
CoreWeave’s most recent earnings were a mixed bag. Revenue for Q4 came in at $1.57 billion, more than double the same quarter a year earlier. That’s a genuinely strong number.
But the company missed on the bottom line. EPS came in at -$0.89 against an expected -$0.61. Net margins were negative at -22.75%, and return on equity was -33.82%.
The results triggered what some analysts called a “capex shock” — investors spooked by the size of 2026 spending guidance. The stock has been under pressure since, trading well below its 52-week high of $187.00.
Its 50-day moving average sits at $88.54 and its 200-day at $98.84 — both well above the current price.
Legal and Insider Pressure
The backdrop isn’t clean. Multiple class-action lawsuits have been filed against the company, alleging securities law violations tied to the Q4 results and infrastructure delays. Several law firms have issued notices to investors.
Insider selling has also attracted attention. Over the last quarter, insiders sold more than 4.3 million shares worth over $373 million. CFO Nitin Agrawal was among those to disclose a sale.
On the institutional side, several new positions were opened in Q2, including by Bank of New York Mellon and Sivia Capital Partners.
Analyst opinion remains divided. Loop Capital has a Buy rating with a $120 target. Mizuho and UBS both rate it Neutral. Bernstein has issued an underperform view with a target around $56. Bank of America cut its target from $168 to $140 but kept a Neutral rating.
The consensus across 32 analysts is a Moderate Buy, with an average target of $122.35.
On the business side, CoreWeave recently signed a multi-year partnership with Perplexity to handle AI inference workloads — a deal that analysts say reinforces its position in a high-margin part of the market.
The stock opened Friday at $72.83 with a market cap of $30.52 billion.





